Question

Suppose a patient is given 140 mg of I−131, a beta emitter with a half-life of...

Suppose a patient is given 140 mg of I−131, a beta emitter with a half-life of 8.0 days.Assuming that none of the I−131 is eliminated from the person's body in the first 4.0 hours of treatment, what is the exposure (in Ci) during those first four hours?(give correct solution)

Homework Answers

Answer #1

Answer: According to the question , Here the

Four hours is = 4 hours / (8*24) hours = 0.0208 half-lives.

Now , in after 4 hours we have = 0.0208 * 70 mg of I-131

= 1.96 mg

Hecne the after 4 hours the reaming amount is = 140 - 1.96 = 138.04 mg of I- 131

this means that 1.96 mg of I-131 released a beta particle .

Now , The number of mg divided by 1000 (to give grams), then divided by 131 (the atomic mass) will give the moles of Iodine. Multiply the moles by 6.022 * 10^23 to get the number of atoms of I-131 which decayed during the 4 hours.

Hence we get = 9.010 * 1018  atoms

Hence it is all about the given question . Thank you :)

Know the answer?
Your Answer:

Post as a guest

Your Name:

What's your source?

Earn Coins

Coins can be redeemed for fabulous gifts.

Not the answer you're looking for?
Ask your own homework help question
Similar Questions
A patient ingests 140 mg of 131I (iodine-131), a beta emitter with a half-life of 8.0...
A patient ingests 140 mg of 131I (iodine-131), a beta emitter with a half-life of 8.0 days. Assuming that none of the 131I is eliminated from the person's body in the first 4.0 hours of treatment, what is the exposure (in Ci) during those 4.0 hours? Express your answer using two significant figures. exposure= _____ Ci
Bismuth-210 is beta emitter with a half-life of 5.0 days. Part A If a sample contains...
Bismuth-210 is beta emitter with a half-life of 5.0 days. Part A If a sample contains 1.3 g of Bi-210 (atomic mass = 209.984105 amu), how many beta emissions occur in 14.0 days? Express your answer using two significant figures. betadecays Part B If a person's body intercepts 5.5 % of those emissions, to what dose of radiation (in Ci) is the person exposed? Express your answer using two significant figures. Dose of radiation = Ci
An 85 kg patient swallows a 30 μCi beta emitter with a half-life of 5.0 days,...
An 85 kg patient swallows a 30 μCi beta emitter with a half-life of 5.0 days, and the radioactive nuclei are quickly distributed throughout his body. The beta particles are emitted with an average energy of 0.35 MeV, 90% of which is absorbed by the body. What dose equivalent does the patient receive in the first week?
A patient is given 0.045 mg of technetium-99 m , a radioactive isotope with a half-life...
A patient is given 0.045 mg of technetium-99 m , a radioactive isotope with a half-life of about 6.0 hours. How long does it take for the radioactive isotope to decay to 8.0×10−4 mg ? (Assume no excretion of the nuclide from the body.)
How many mg (to 3 decimal places) of I-131 with half life of 8.07 days remain...
How many mg (to 3 decimal places) of I-131 with half life of 8.07 days remain from a 5.0 mg sample after 15.6 days?
given a radiotracer Technetium-99m with a half-life of 6 hours and a photon energy of 140...
given a radiotracer Technetium-99m with a half-life of 6 hours and a photon energy of 140 keV or an Iodine-131 with a half-life of 8.04 days and a photon energy of 364 keV, which one would be better to use on a patient if you wanted to take one 30-minute image a day to track a new cancer therapy over 6 days? Explain your answer.
The iodine isotope 131 53 I (half-life = 8 days, atomic mass = 131 u) is...
The iodine isotope 131 53 I (half-life = 8 days, atomic mass = 131 u) is used in hospitals for diagnosis of thyroid function. (1 u = 1.66 x 10-27 kg). If 682 μg (1 μg = 10-6 g) are ingested by a patient, determine the activity (a) Immediately (b) One hour later, when the thyroid is being tested (c) Six months later (assume the iodine is still in the patient’s body)
At 8:00 A.M., a patient receives a 1.1-μg dose of I-131 to treat thyroid cancer. Part...
At 8:00 A.M., a patient receives a 1.1-μg dose of I-131 to treat thyroid cancer. Part A: If the nuclide has a half-life of 8.0 days, what mass of the nuclide remains in the patient at 4:00 P.M. the next day? (Assume no excretion of the nuclide from the body.) Express your answer using two significant figures. m =   μg  
At 8:00 A.M., a patient receives a 1.1-μg dose of I-131 to treat thyroid cancer. Part...
At 8:00 A.M., a patient receives a 1.1-μg dose of I-131 to treat thyroid cancer. Part A If the nuclide has a half-life of 8.0 days, what mass of the nuclide remains in the patient at 4:00 P.M. the next day? (Assume no excretion of the nuclide from the body.) Express your answer using two significant figures. m =   μg  
Objective: The student will apply course objectives through evaluating patient assessments, identifying treatment options and developing...
Objective: The student will apply course objectives through evaluating patient assessments, identifying treatment options and developing teaching plans for patients with obesity, peptic ulcer disease (PUD) and gastroesophageal reflux disease (GERD). Part I: Obesity & Bariatric Surgery A 32-year-old obese patient has come to the bariatric outpatient center to have an initial evaluation. The patient reports that they were always overweight, even as a child. The patient states that they are frustrated because they gained 100 pounds over the last...
ADVERTISEMENT
Need Online Homework Help?

Get Answers For Free
Most questions answered within 1 hours.

Ask a Question
ADVERTISEMENT